Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening

D Hashim, B Engesæter, G Baadstrand Skare… - British Journal of …, 2020 - nature.com
Background HPV16/18 detection may improve cervical cancer risk stratification and better
guide which HPV-positive women warrant immediate colposcopy/biopsy. We estimated risks …

Precancerous lesions of the cervix—aetiology, classification, diagnosis, prevention

Y Kornovski, S Slavchev, S Kostov… - Oncology in Clinical …, 2021 - journals.viamedica.pl
The present review introduces the aetiology and classification of cervical precancers. The
principles of diagnosis based on colposcopy are reviewed. The indications for colposcopy …

Human Papillomavirus Intermittence and Risk Factors Associated With First Detections and Redetections in the Ludwig-McGill Cohort Study of Adult Women

T Malagón, H Trottier, M El-Zein, LL Villa… - The Journal of …, 2023 - academic.oup.com
Background We assessed the incidence and risk factors for first detection and redetection
with the same human papillomavirus (HPV) genotype, and prevalence of cytological lesions …

A study of the risks of CIN3+ detection after multiple rounds of HPV testing: results of the 15‐year cervical cancer screening experience at Kaiser Permanente northern …

A Hammer, M Demarco, N Campos… - … Journal of Cancer, 2020 - Wiley Online Library
Many countries are transitioning to HPV testing for cervical cancer screening, despite a lack
of long‐term experience. To anticipate multi‐round screening performance, we analyzed 15 …

[HTML][HTML] Human papillomavirus negative high grade cervical lesions and cancers: Suggested guidance for HPV testing quality assurance

JL Prétet, LSA Mühr, K Cuschieri, MD Fellner… - Journal of Clinical …, 2024 - Elsevier
Background Some high-grade cervical lesions and cervical cancers (HSIL+) test negative for
human papillomavirus (HPV). The HPV-negative fraction varies between 0.03% and 15 …

Prevalence of high-grade dysplasia in cytology-negative, HPV-positive cervical cancer screening

SM Peace, AJ Jennings - Archives of gynecology and obstetrics, 2022 - Springer
Purpose This study has two aims: determine the prevalence of CIN3+ in patients with
discordant cotesting, defined as negative cytology and positive human papillomavirus (HPV) …

Human papillomavirus intermittence, redetections, and associated risk of cytological abnormalities in the Ludwig-McGill cohort study of adult women

T Malagón, H Trottier, M El-Zein, LL Villa, E Franco… - medRxiv, 2022 - medrxiv.org
Introduction We assessed the incidence of redetection with the same human papillomavirus
(HPV) genotype, predictors of first HPV detections and redetections, and prevalence of …

A Population-based Study on Cervical Cancer Screening in Germany: Beyond the Baseline

LAB Liang - 2023 - mediatum.ub.tum.de
Screening is a crucial preventive measure for cervical cancer, but traditional cytology
screening has limitations in detecting disease, especially with modern Human …

Effect of sequential rounds of cervical cancer screening on management of HPV-positive women: A 15-year population-based cohort study from China

XQ Xu, R Rezhake, SY Hu, F Chen, X Zhang… - Cancer Prevention …, 2021 - AACR
Women are anticipated to go through more than two rounds of cervical screening in their
lifetime. Human papillomavirus (HPV) testing is increasingly used as the primary cervical …

Is it Really Necessary to Perform Colposcopy in Patients with Ascus and HR HPV Positivity?

S Özaltın - Acıbadem Üniversitesi Sağlık Bilimleri Dergisi, 2022 - journal.acibadem.edu.tr
IS IT REALLY NECESSARY TO PERFORM COLPOSCOPY IN PATIENTS WITH ASCUS
AND HR HPV POSITIVITY? INTRODUCTION: Papanicolaou (Pap) smear is a very important …